Procyanidin, a kind of biological flavonoid, induces protective anti-tumor immunity and protects mice from lethal B16F10 challenge
Authors:
- 1 June 2017
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 47, 251-258
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma modelMelanoma Research, 2012
- Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumorsCancer Immunology, Immunotherapy, 2011
- Trp2 Peptide Vaccine Adjuvanted with (R)-DOTAP Inhibits Tumor Growth in an Advanced Melanoma ModelMolecular Pharmaceutics, 2011
- Oligomeric procyanidins stimulate innate antiviral immunity in dengue virus infected human PBMCsAntiviral Research, 2011
- Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunityBMC Immunology, 2010
- Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in MicePLOS ONE, 2010
- Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma modelClinical Immunology, 2008
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinomaProceedings of the National Academy of Sciences of the United States of America, 2007